Neon Bloom, Inc. (OTC: NBCO), is proud to announce it has closed on the acquisition of Bazelet Health Systems, Inc. This acquisition was an all-stock purchase of 120,000,000 Neon Bloom, Inc. common shares for 100% of the outstanding shares of Bazelet Health Systems, Inc.
“Bazelet Corporation has the remarkable opportunity to lead the scientific expansion and commercialization of THC Free cannabis, further revolutionizing the field of genome engineering and sequencing.” Said Michael Clinton, Bazelet co-founder.
Bazelet Health Systems has three operating subsidiaries: Bazelet Oglesby, Bazelet Research and Innovation, and Bazelet Learning.
- Bazelet Oglesby is an innovative, forward-thinking plant science company establishing itself as a world leader in tissue culture propagation and the production of young plants for the global horticulture industry.
- Bazelet Research and Innovation are revolutionizing the field of genome engineering and sequencing using CRISPR-Cas9. This new technology empowers the company with limitless applications in disease therapeutics, drug discovery, agriculture, biofuels, and more. Bazelet Research is pinpointing correlations between the genetic effects of certain cannabis strains for optimal industrial, medicinal, and consumer application.
- Bazelet Learning offers comprehensive, accredited cannabis educational coursework with learning programs intended for academic institutions, physicians and healthcare, patients, consumers, government, and non-government organizations.
“The acquisition of Bazelet Health Systems brings immense value to our shareholders and immediately puts Neon Bloom, Inc. in the global forefront of the legal cannabis/hemp industry.” Said David Grand, Bazelet co-founder and Director of Research.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Source: biospace